Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Combined Collagen Crosslinking/Ultraviolet-A and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potentially Elevated Risk of Ectasia

Study:

Combined Collagen Crosslinking/Ultraviolet-A and Photorefractive Keratectomy or LASIK in Forme Fruste Keratoconus or Eyes With Potentially Elevated Risk of Ectasia

Rationale:

n/a

Purpose:

This study is being performed to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) in strengthening and optimizing the biomechanical and biochemical stability of the cornea in patients with fruste keratoconus (FFKC), corneas that are suspicious for FFKC and corneas thought to be at higher risk of developing ectasia that will be undergoing laser vision correction.

Study Status: Recruiting

Recruiting:
n/a

Condition Intervention Phase
Fruste Keratoconus
Risk of Ectasia
Device: Corneal Cross-Linking
Drug: Riboflavin
N/A

Verified by Cxlusa November, 2012

Sponsored by: Cxlusa
Information provided by: Cxlusa
ClinicalTrials.gov identifier: NCT01726283

Study Type: Interventional

Study Design: Observational Model: Case-Only, Time Perspective: Prospective

n/a William Trattler, MD., Study Director
Roy Rubinfeld., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site